Sanofi (SAN)

Por gentileza de Clicktrader

Paris, Geneva and Nairobi. December 15, 2023. Sanofi, DNDi and the HAT-r-ACC consortium announce the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense). This positive opinion is for the treatment in adults and children six years of age or older and weighing at least 20 kg, of both first-stage (haemo-lymphatic) and second-stage (meningo-encephalitic) Trypanosoma brucei (T.b.) rhodesiense sleeping sickness, an acute and lethal form of this parasitic disease found in Eastern and Southern Africa.

Estas las vendí a finales del año pasado pensando que malvendía

Las farmas se están cubriendo de gloria con sus spin offs

Sube el divi un 5.6% hasta 3.76€

4 Likes

menos mal que he acertado con alguna :smiley:

https://seekingalpha.com/news/4061034-sanofi-non-gaap-eps-of-166-revenue-of-1092b-initiates-fy24-outlook